Skip to content

Foresite Capital Management VI LLC

Follow

13F filer, CIK 2013341, West Hollywood, CA

Foresite Capital Management VI LLC reported $566,360,650 across 22 holdings for the quarter ended 2026-09-30, in a 13F-HR filed 2026-11-16. Its ten largest share positions make up 77.7% of the portfolio.

Accepted , ingested 13F-HR 0001104659-26-128383

Period
2026-09-30
Reported value
$566M
Holdings
22
Top 10 weight
77.7%
New
4
Sold out
5

Part of the filer group Foresite Capital Management VI LLC

How groups are built

Stakes and trades reported after 2026-09-30

13D, 13G and Form 4 filings by this filer's group, dated after the 13F period, on securities the quarter does not hold as shares.

  • IRLA QUINCE THERAPEUTICS INC: 13G 652,039 shares, 6% of the class, 13G filed 2026-10-14, 0001104659-26-115859Timeline
    Accepted , ingested

Largest buys vs the previous quarter

SecurityShares changeApprox. value
KRSAnew+1,431,660$45.8M
LTGOnew+2,203,800$36.8M
OBXnew+916,063$12.6M
AVBPadded+189,000$5.72M
ZURAadded+1,307,000$5.44M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Largest sells vs the previous quarter

SecurityShares changeApprox. value
CLDXexited-879,713-$32.7M
CGONreduced-260,000-$18.4M
ATAIexited-2,750,000-$14.5M
HNGEreduced-112,300-$10.9M
CRNXexited-212,010-$7.93M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Holdings, Q3 2026

Share positions as resolved from 13F-HR 0001104659-26-128383, largest first. % of portfolio is the value over $566,360,650, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
CGONCG ONCOLOGY INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 2,221,474 shares; 2025Q1: 2,221,474 shares; 2025Q2: 2,221,474 shares; 2025Q3: 2,221,474 shares; 2025Q4: 2,221,474 shares; 2026Q1: 2,221,474 shares; 2026Q2: 2,369,574 shares; 2026Q3: 2,109,574 shares 2,109,574$150M26.41%-260,000Timeline
KRSAKORSANA BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 1,431,660 shares 1,431,660$45.8M8.09%newTimeline
LTGOLATIGO BIOTHERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 2,203,800 shares 2,203,800$36.8M6.5%newTimeline
SPTXSEAPORT THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 1,779,521 shares; 2026Q3: 1,779,521 shares 1,779,521$35.9M6.34%0Timeline
DNLIDENALI THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 1,000,000 shares; 2025Q4: 1,000,000 shares; 2026Q1: 1,209,971 shares; 2026Q2: 1,396,771 shares; 2026Q3: 1,617,771 shares 1,617,771$33.4M5.9%+221,000Timeline
PBLSPARABILIS MEDICINES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 999,044 shares; 2026Q3: 999,044 shares 999,044$32.3M5.7%0Timeline
ALMSALUMIS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 4,202,670 shares; 2025Q1: 4,202,670 shares; 2025Q2: 4,247,670 shares; 2025Q3: 4,247,670 shares; 2025Q4: 4,247,670 shares; 2026Q1: 4,247,670 shares; 2026Q2: 4,247,670 shares; 2026Q3: 4,247,670 shares 4,247,670$31.4M5.54%0Timeline
AGIOAGIOS PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 530,000 shares; 2026Q1: 525,000 shares; 2026Q2: 785,000 shares; 2026Q3: 827,128 shares 827,128$27.5M4.86%+42,128Timeline
VSTMVERASTEM INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 1,276,520 shares; 2025Q3: 2,615,120 shares; 2025Q4: 3,135,120 shares; 2026Q1: 3,146,631 shares; 2026Q2: 3,146,631 shares; 2026Q3: 3,146,631 shares 3,146,631$25.3M4.47%0Timeline
GHRSGH RESEARCH PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 315,492 shares; 2026Q2: 940,493 shares; 2026Q3: 940,493 shares 940,493$22.1M3.9%0Timeline
CRVSCORVUS PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 1,581,233 shares; 2025Q1: 1,581,233 shares; 2025Q2: 1,731,233 shares; 2025Q3: 1,731,233 shares; 2025Q4: 1,381,233 shares; 2026Q1: 1,831,233 shares; 2026Q2: 1,831,233 shares; 2026Q3: 1,831,233 shares 1,831,233$21.1M3.72%0Timeline
KYMRKYMERA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 146,332 shares; 2025Q1: 146,332 shares; 2025Q2: 146,332 shares; 2025Q3: 146,332 shares; 2025Q4: 146,332 shares; 2026Q1: 146,332 shares; 2026Q2: 146,332 shares; 2026Q3: 146,332 shares 146,332$16.4M2.89%0Timeline
AVBPARRIVENT BIOPHARMA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 301,341 shares; 2026Q3: 490,341 shares 490,341$14.8M2.62%+189,000Timeline
OBXOBSIDIAN THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 916,063 shares 916,063$12.6M2.22%newTimeline
JBIOJADE BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 320,000 shares; 2026Q2: 886,667 shares; 2026Q3: 886,667 shares 886,667$12.5M2.2%0Timeline
HNGEHINGE HEALTH INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 135,000 shares; 2025Q3: 135,000 shares; 2025Q4: 135,000 shares; 2026Q1: 220,400 shares; 2026Q2: 220,400 shares; 2026Q3: 108,100 shares 108,100$10.5M1.86%-112,300Timeline
AURAAURA BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 1,333,334 shares; 2026Q3: 1,333,334 shares 1,333,334$8.37M1.48%0Timeline
BEAMBEAM THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 330,000 shares; 2026Q3: 330,000 shares 330,000$8.07M1.42%0Timeline
ZURAZURA BIO LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 450,000 shares; 2026Q2: 450,000 shares; 2026Q3: 1,757,000 shares 1,757,000$7.31M1.29%+1,307,000Timeline
NERVMINERVA NEUROSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 1,986,600 shares; 2026Q2: 1,985,584 shares; 2026Q3: 1,985,584 shares 1,985,584$6.65M1.17%0Timeline
IRONDISC MEDICINE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 970 shares; 2026Q3: 68,470 shares 68,470$4.48M0.79%+67,500Timeline
ENTXENTERA BIO LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 1,225,490 shares 1,225,490$3.57M0.63%newTimeline

Sold out in Q3 2026

Positions in the previous quarter's report that this quarter's report no longer lists.

SecurityShares beforeValue beforeType
CLDXCELLDEX THERAPEUTICS INC NEW879,713$32.7Mshares
ATAIATAIBECKLEY INC2,750,000$14.5Mshares
CRNXCRINETICS PHARMACEUTICALS IN212,010$7.93Mshares
RACCRESEARCH ALLIANCE CORP III300,000$3.21Mshares
KLRAKAILERA THERAPEUTICS INC37,500$826Kshares

How Q3 2026 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0001104659-26-128383 base2026-11-16